订阅小程序
旧版功能

A Phase II/III Randomized Double-Blind Study of Octreotide Acetate LAR with Axitinib Versus Octreotide Acetate LAR with Placebo in Patients with Advanced G1-G2 NETs of Non-Pancreatic Origin (AXINET Trial-Getne-1107).

Rocio Garcia-Carbonero,Marta Benavent,Paula Jimenez Fonseca,Daniel Castellano,Teresa Alonso,Alex Teule,Ana Custodio,Salvatore Tafuto,Adelaida La Casta Munoa,Francesca Spada,Carlos Lopez-Lopez,Toni Ibrahim,Maria Jose Villanueva Silva,Vega Iranzo,Pilar Garcia-Alfonso,Encarnacion Gonzalez,Enrique Grande,Guillermo Crespo,Jaume Capdevila

Journal of Clinical Oncology（2021）

引用 24|浏览46
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要